Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders.
Quantification of relevance of quality of life assessment for patients with cognitive impairment: the suitability indices.
EBV & HHV6 reactivation is infrequent and not associated with MS clinical course.
Quantitative proteome profiling of CNS-infiltrating autoreactive CD4(+) cells reveals selective changes during experimental autoimmune encephalomyelitis.
Current management of relapsing-remitting multiple sclerosis.
Natural Killer Cell Subsets in Cerebrospinal Fluid of Patients with Multiple Sclerosis.
Technical developments of functional electrical stimulation to correct drop foot: Sensing, actuation and control strategies.
Evaluation of the effects of group psychotherapy on cognitive function in patients with multiple sclerosis with cognitive dysfunction and depression.
Traumatic fatal cerebral hemorrhage in an old patient with a history of multiple sclerosis under dabigatran: a case report and review of the literature.
Cytokines and chemokines in multiple sclerosis.
A New Zealand pilot randomized controlled trial of a web-based interactive self-management programme (MSInvigor8) with and without email support for the treatment of multiple sclerosis fatigue.
Walking function in clinical monitoring of multiple sclerosis by telemedicine.
A case of IgM paraproteinemic neuropathy associated with anti-sulfated glucuronic paragloboside (SGPG) IgG antibody without anti-myelin-associated glycoprotein (MAG) activity.
Improved differentiation between MS and vascular brain lesions using FLAIR* at 7 Tesla.
Structural correlates of subjective and objective memory performance in multiple sclerosis.
Validity of Minimal Clinically Important Difference Values for the Multiple Sclerosis Walking Scale-12?
Low sensitivity to glucocorticoid inhibition of in vitro Th17-related cytokine production in multiple sclerosis patients is related to elevated plasma lipopolysaccharide levels.
Symptomatic Sinus Bradycardia After a Treatment Course Of High-dose Oral Prednisone.
A prospective study of "undiagnosed" isolated myelopathy: I. Case selection and clinical features.
Multiple sclerosis-associated retrovirus and related human endogenous retrovirus-W in patients with multiple sclerosis.
Treatment Against Human Endogenous Retrovirus: A Possible Personalized Medicine Approach for Multiple Sclerosis.
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis.
The multiple sclerosis-associated regulatory variant rs10877013 affects expression of CYP27B1 and VDR under inflammatory or vitamin D stimuli.
Impact of oral health in patients with multiple sclerosis and epilepsy: A survey in a neurology clinic.
Breastfeeding and Disease-Modifying Therapy for Multiple Sclerosis.
Pages
« first
‹ previous
…
497
498
499
500
501
502
503
504
505
…
next ›
last »